Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

Ensaio clínico

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain

NCT: NCT07568015 · RECRUITING

ID NCTNCT07568015
EstadoRECRUITING
Data de início2026-07-27
Conclusão2029-11-01
SponsorBrixton Biosciences, Inc. (INDUSTRY)
First posted
Last updated

Resumo breve

The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.

Fonte oficial

Ver no ClinicalTrials.gov →

Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.

↑